問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
陳彥舟
下載
2025-03-01 - 2030-06-30
Condition/Disease
The time elapsed before the first occurrence of any of the following events: • Hospitalization due to HF • Non-hospitalized HF • Death due to CV
Test Drug
Baxdrostat Dapagliflozin
Participate Sites18Sites
Recruiting18Sites
2025-07-01 - 2030-12-31
Participate Sites23Sites
Recruiting23Sites
2026-06-01 - 2030-06-30
Participate Sites14Sites
Recruiting14Sites
2024-02-01 - 2028-12-31
Participate Sites11Sites
Recruiting11Sites
2026-01-02 - 2029-09-30
Participate Sites6Sites
Not yet recruiting1Sites
Recruiting5Sites
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2025-08-01 - 2031-03-31
Participate Sites8Sites
Recruiting8Sites
2025-05-01 - 2029-06-30
2025-09-30 - 2032-03-31
2026-02-13 - 2029-03-22
Participate Sites9Sites
Recruiting9Sites
全部
